Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 325

    1.

    Coadministration of nanosystems of short silencing RNAs targeting oestrogen receptor alpha and anti-oestrogen synergistically induces tumour growth inhibition in human breast cancer xenografts.

    Bouclier C, Marsaud V, Bawa O, Nicolas V, Moine L, Opolon P, Renoir JM.

    Breast Cancer Res Treat. 2009 Sep 22. [Epub ahead of print]PMID: 19771505 [PubMed - as supplied by publisher]Related articles

    2.

    The aurora B kinase inhibitor AZD1152 sensitizes cancer cells to fractionated irradiation and induces mitotic catastrophe.

    Tao Y, Leteur C, Calderaro J, Girdler F, Zhang P, Frascogna V, Varna M, Opolon P, Castedo M, Bourhis J, Kroemer G, Deutsch E.

    Cell Cycle. 2009 Oct 1;8(19):3172-81. Epub 2009 Oct 4.PMID: 19755861 [PubMed - in process]Related articles

    3.

    Syncytin-A knockout mice demonstrate the critical role in placentation of a fusogenic, endogenous retrovirus-derived, envelope gene.

    Dupressoir A, Vernochet C, Bawa O, Harper F, Pierron G, Opolon P, Heidmann T.

    Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12127-32. Epub 2009 Jun 29.PMID: 19564597 [PubMed - indexed for MEDLINE]Related articles

    4.

    Differential effect triggered by a heparan mimetic of the RGTA family preventing oral mucositis without tumor protection.

    Mangoni M, Yue X, Morin C, Violot D, Frascogna V, Tao Y, Opolon P, Castaing M, Auperin A, Biti G, Barritault D, Vozenin-Brotons MC, Deutsch E, Bourhis J.

    Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1242-50.PMID: 19545790 [PubMed - indexed for MEDLINE]Related articles

    5.

    Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium.

    Geoerger B, Morland B, Ndiaye A, Doz F, Kalifa G, Geoffray A, Pichon F, Frappaz D, Chatelut E, Opolon P, Hain S, Boderet F, Bosq J, Emile JF, Le Deley MC, Capdeville R, Vassal G; Innovative Therapies for Children with Cancer European Consortium.

    Eur J Cancer. 2009 Sep;45(13):2342-51. Epub 2009 Apr 9.PMID: 19362466 [PubMed - indexed for MEDLINE]Related articles

    6.

    Novel anti-metastatic action of cidofovir mediated by inhibition of E6/E7, CXCR4 and Rho/ROCK signaling in HPV tumor cells.

    Amine A, Rivera S, Opolon P, Dekkal M, Biard DS, Bouamar H, Louache F, McKay MJ, Bourhis J, Deutsch E, Vozenin-Brotons MC.

    PLoS One. 2009;4(3):e5018. Epub 2009 Mar 26.PMID: 19325708 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS.

    Zanta-Boussif MA, Charrier S, Brice-Ouzet A, Martin S, Opolon P, Thrasher AJ, Hope TJ, Galy A.

    Gene Ther. 2009 May;16(5):605-19. Epub 2009 Mar 5.PMID: 19262615 [PubMed - in process]Related articles

    8.

    Cooperative effect of roscovitine and irradiation targets angiogenesis and induces vascular destabilization in human breast carcinoma.

    Maggiorella L, Aubel C, Haton C, Milliat F, Connault E, Opolon P, Deutsch E, Bourhis J.

    Cell Prolif. 2009 Feb;42(1):38-48.PMID: 19143762 [PubMed - indexed for MEDLINE]Related articles

    9.

    Prevention of autoimmunity and control of recall response to exogenous antigen by Fas death receptor ligand expression on T cells.

    Mabrouk I, Buart S, Hasmim M, Michiels C, Connault E, Opolon P, Chiocchia G, Lévi-Strauss M, Chouaib S, Karray S.

    Immunity. 2008 Dec 19;29(6):922-33. Epub 2008 Nov 13.PMID: 19013083 [PubMed - indexed for MEDLINE]Related articles

    10.

    New potential and applications of contrast-enhanced ultrasound of the breast: Own investigations and review of the literature.

    Balleyguier C, Opolon P, Mathieu MC, Athanasiou A, Garbay JR, Delaloge S, Dromain C.

    Eur J Radiol. 2009 Jan;69(1):14-23. Epub 2008 Oct 31. Review.PMID: 18977102 [PubMed - indexed for MEDLINE]Related articles

    11.

    16-kDa fragment of pleiotrophin acts on endothelial and breast tumor cells and inhibits tumor development.

    Ducès A, Karaky R, Martel-Renoir D, Mir L, Hamma-Kourbali Y, Biéche I, Opolon P, Delbé J, Courty J, Perricaudet M, Griscelli F.

    Mol Cancer Ther. 2008 Sep;7(9):2817-27.PMID: 18790762 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Physicochemical characteristics and preliminary in vivo biological evaluation of nanocapsules loaded with siRNA targeting estrogen receptor alpha.

    Bouclier C, Moine L, Hillaireau H, Marsaud V, Connault E, Opolon P, Couvreur P, Fattal E, Renoir JM.

    Biomacromolecules. 2008 Oct;9(10):2881-90. Epub 2008 Sep 13.PMID: 18788777 [PubMed - indexed for MEDLINE]Related articles

    13.

    Antitumoral activity and osteogenic potential of mesenchymal stem cells expressing the urokinase-type plasminogen antagonist amino-terminal fragment in a murine model of osteolytic tumor.

    Fritz V, Noël D, Bouquet C, Opolon P, Voide R, Apparailly F, Louis-Plence P, Bouffi C, Drissi H, Xie C, Perricaudet M, Müller R, Schwarz E, Jorgensen C.

    Stem Cells. 2008 Nov;26(11):2981-90. Epub 2008 Aug 28.PMID: 18757301 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Reduction of brain metastases in plasminogen activator inhibitor-1-deficient mice with transgenic ocular tumors.

    Maillard CM, Bouquet C, Petitjean MM, Mestdagt M, Frau E, Jost M, Masset AM, Opolon PH, Beermann F, Abitbol MM, Foidart JM, Perricaudet MJ, Noël AC.

    Carcinogenesis. 2008 Nov;29(11):2236-42. Epub 2008 Aug 27.PMID: 18753414 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver.

    Vigant F, Descamps D, Jullienne B, Esselin S, Connault E, Opolon P, Tordjmann T, Vigne E, Perricaudet M, Benihoud K.

    Mol Ther. 2008 Aug;16(8):1474-80. Epub 2008 Jun 17.PMID: 18560416 [PubMed - indexed for MEDLINE]Related articles

    16.

    Canstatin gene electrotransfer combined with radiotherapy: preclinical trials for cancer treatment.

    Magnon C, Opolon P, Connault E, Mir LM, Perricaudet M, Martel-Renoir D.

    Gene Ther. 2008 Nov;15(21):1436-45. Epub 2008 Jun 12.PMID: 18548116 [PubMed - indexed for MEDLINE]Related articles

    17.

    EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenografts.

    Geoerger B, Gaspar N, Opolon P, Morizet J, Devanz P, Lecluse Y, Valent A, Lacroix L, Grill J, Vassal G.

    Int J Cancer. 2008 Jul 1;123(1):209-16.PMID: 18386816 [PubMed - indexed for MEDLINE]Related articles

    18.

    Tumor destruction using electrochemotherapy followed by CpG oligodeoxynucleotide injection induces distant tumor responses.

    Roux S, Bernat C, Al-Sakere B, Ghiringhelli F, Opolon P, Carpentier AF, Zitvogel L, Mir LM, Robert C.

    Cancer Immunol Immunother. 2008 Sep;57(9):1291-300. Epub 2008 Feb 8.PMID: 18259749 [PubMed - indexed for MEDLINE]Related articles

    19.

    Acoustic characterization of a new trisacryl contrast agent. Part II: Flow phantom study and in vivo quantification.

    Lavisse S, Peronneau P, Rouffiac V, Paci A, Vigouroux J, Opolon P, Roche A, Lassau N.

    Ultrasonics. 2008 Mar;48(1):26-34. Epub 2007 Dec 4.PMID: 18191434 [PubMed - indexed for MEDLINE]Related articles

    20.

    Tumor ablation with irreversible electroporation.

    Al-Sakere B, André F, Bernat C, Connault E, Opolon P, Davalos RV, Rubinsky B, Mir LM.

    PLoS One. 2007 Nov 7;2(11):e1135.PMID: 17989772 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    A study of the immunological response to tumor ablation with irreversible electroporation.

    Al-Sakere B, Bernat C, Andre F, Connault E, Opolon P, Davalos RV, Mir LM.

    Technol Cancer Res Treat. 2007 Aug;6(4):301-6.PMID: 17668937 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Membrane-bound interleukin (IL)-15 on renal tumor cells rescues natural killer cells from IL-2 starvation-induced apoptosis.

    Wittnebel S, Da Rocha S, Giron-Michel J, Jalil A, Opolon P, Escudier B, Validire P, Khawam K, Chouaib S, Azzarone B, Caignard A.

    Cancer Res. 2007 Jun 15;67(12):5594-9.PMID: 17575122 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Radiation and inhibition of angiogenesis by canstatin synergize to induce HIF-1alpha-mediated tumor apoptotic switch.

    Magnon C, Opolon P, Ricard M, Connault E, Ardouin P, Galaup A, Métivier D, Bidart JM, Germain S, Perricaudet M, Schlumberger M.

    J Clin Invest. 2007 Jul;117(7):1844-55.PMID: 17557121 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Methodology for quantifying interactions between perfusion evaluated by DCE-US and hypoxia throughout tumor growth.

    Elie N, Kaliski A, Péronneau P, Opolon P, Roche A, Lassau N.

    Ultrasound Med Biol. 2007 Apr;33(4):549-60.PMID: 17350158 [PubMed - indexed for MEDLINE]Related articles

    25.

    Induction of glutathione synthesis explains pharmacodynamics of high-dose busulfan in mice and highlights putative mechanisms of drug interaction.

    Bouligand J, Deroussent A, Simonnard N, Opolon P, Morizet J, Connault E, Daudigeos E, Re M, Paci A, Vassal G.

    Drug Metab Dispos. 2007 Feb;35(2):306-14. Epub 2006 Nov 28.PMID: 17132762 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness.

    Galaup A, Cazes A, Le Jan S, Philippe J, Connault E, Le Coz E, Mekid H, Mir LM, Opolon P, Corvol P, Monnot C, Germain S.

    Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18721-6. Epub 2006 Nov 27.PMID: 17130448 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Respective roles of TNF-alpha and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice.

    Benihoud K, Esselin S, Descamps D, Jullienne B, Salone B, Bobé P, Bonardelle D, Connault E, Opolon P, Saggio I, Perricaudet M.

    Gene Ther. 2007 Mar;14(6):533-44. Epub 2006 Nov 16. Erratum in: Gene Ther. 2007 Mar;14(6):551. PMID: 17109009 [PubMed - indexed for MEDLINE]Related articles

    28.

    A gene transfer comparative study of HSA-conjugated antiangiogenic factors in a transgenic mouse model of metastatic ocular cancer.

    Frau E, Magnon C, Opolon P, Connault E, Opolon D, Beermann F, Abitbol M, Perricaudet M, Bouquet C.

    Cancer Gene Ther. 2007 Mar;14(3):251-61. Epub 2006 Nov 3. Erratum in: Cancer Gene Ther. 2007 Apr;14(4):440. Beerman, F [corrected to Beermann, F]. PMID: 17082795 [PubMed - indexed for MEDLINE]Related articles

    29.

    Evaluation of tumor angiogenesis of breast carcinoma using contrast-enhanced digital mammography.

    Dromain C, Balleyguier C, Muller S, Mathieu MC, Rochard F, Opolon P, Sigal R.

    AJR Am J Roentgenol. 2006 Nov;187(5):W528-37.PMID: 17056886 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Improved anti-tumoral capacity of mixed and pure anti-oestrogens in breast cancer cell xenografts after their administration by entrapment in colloidal nanosystems.

    Renoir JM, Stella B, Ameller T, Connault E, Opolon P, Marsaud V.

    J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):114-27. Epub 2006 Oct 23. Review.PMID: 17056251 [PubMed - indexed for MEDLINE]Related articles

    31.

    Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer.

    Pillé JY, Li H, Blot E, Bertrand JR, Pritchard LL, Opolon P, Maksimenko A, Lu H, Vannier JP, Soria J, Malvy C, Soria C.

    Hum Gene Ther. 2006 Oct;17(10):1019-26.PMID: 17007568 [PubMed - indexed for MEDLINE]Related articles

    32.

    Dynamic assessment of antiangiogenic therapy by monitoring both tumoral vascularization and tissue degeneration.

    Magnon C, Galaup A, Rouffiac V, Opolon P, Connault E, Rosé M, Perricaudet M, Roche A, Germain S, Griscelli F, Lassau N.

    Gene Ther. 2007 Jan;14(2):108-17. Epub 2006 Aug 31. Erratum in: Gene Ther. 2007 Jan;14(2):190. PMID: 16943854 [PubMed - indexed for MEDLINE]Related articles

    33.

    Arsenic trioxide: A promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice.

    Bobé P, Bonardelle D, Benihoud K, Opolon P, Chelbi-Alix MK.

    Blood. 2006 Dec 15;108(13):3967-75. Epub 2006 Aug 22.PMID: 16926289 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Expression of non-signaling membrane-anchored death receptors protects murine livers in different models of hepatitis.

    Descamps D, Vigant F, Esselin S, Connault E, Opolon P, Perricaudet M, Benihoud K.

    Hepatology. 2006 Aug;44(2):399-409.PMID: 16871589 [PubMed - indexed for MEDLINE]Related articles

    35.

    Variability of naked DNA expression after direct local injection: the influence of the injection speed.

    André FM, Cournil-Henrionnet C, Vernerey D, Opolon P, Mir LM.

    Gene Ther. 2006 Dec;13(23):1619-27. Epub 2006 Jul 27.PMID: 16871232 [PubMed - indexed for MEDLINE]Related articles

    36.

    A soluble truncated cadherin induces breast cancer cell apoptosis and growth inhibition.

    Shi XY, Lu H, Li WL, Tang HL, Xiong JJ, Zhang JQ, Opolon P, Legrand C, Perricaudet M, Li H.

    J Cancer Res Clin Oncol. 2006 Sep;132(9):561-71. Epub 2006 Jun 9.PMID: 16763806 [PubMed - indexed for MEDLINE]Related articles

    37.

    Improved antitumoral properties of pure antiestrogen RU 58668-loaded liposomes in multiple myeloma.

    Maillard S, Gauduchon J, Marsaud V, Gouilleux F, Connault E, Opolon P, Fattal E, Sola B, Renoir JM.

    J Steroid Biochem Mol Biol. 2006 Jul;100(1-3):67-78. Epub 2006 Jun 5.PMID: 16753295 [PubMed - indexed for MEDLINE]Related articles

    38.

    Combination of HIFU therapy with contrast-enhanced sonography for quantitative assessment of therapeutic efficiency on tumor grafted mice.

    Rouffiac V, Duret JS, Péronneau P, Dehez N, Opolon P, Roche A, Lassau N.

    Ultrasound Med Biol. 2006 May;32(5):729-40.PMID: 16677932 [PubMed - indexed for MEDLINE]Related articles

    39.

    Suppression of angiogenesis, tumor growth, and metastasis by adenovirus-mediated gene transfer of human angiotensinogen.

    Bouquet C, Lamandé N, Brand M, Gasc JM, Jullienne B, Faure G, Griscelli F, Opolon P, Connault E, Perricaudet M, Corvol P.

    Mol Ther. 2006 Aug;14(2):175-82. Epub 2006 Apr 5.PMID: 16600689 [PubMed - indexed for MEDLINE]Related articles

    40.

    Pleiotrophin, a candidate gene for poor tumor vasculature and in vivo neuroblastoma sensitivity to irinotecan.

    Calvet L, Geoerger B, Regairaz M, Opolon P, Machet L, Morizet J, Joseph JM, Elie N, Vassal G.

    Oncogene. 2006 May 25;25(22):3150-9.PMID: 16501609 [PubMed - indexed for MEDLINE]Related articles

    41.

    A novel dendritic cell subset involved in tumor immunosurveillance.

    Taieb J, Chaput N, Ménard C, Apetoh L, Ullrich E, Bonmort M, Péquignot M, Casares N, Terme M, Flament C, Opolon P, Lecluse Y, Métivier D, Tomasello E, Vivier E, Ghiringhelli F, Martin F, Klatzmann D, Poynard T, Tursz T, Raposo G, Yagita H, Ryffel B, Kroemer G, Zitvogel L.

    Nat Med. 2006 Feb;12(2):214-9. Epub 2006 Jan 29.PMID: 16444265 [PubMed - indexed for MEDLINE]Related articles

    42.

    Combined radiation sensitizing and anti-angiogenic effects of ionizing radiation and the protease inhibitor ritonavir in a head and neck carcinoma model.

    Maggiorella L, Wen B, Frascogna V, Opolon P, Bourhis J, Deutsch E.

    Anticancer Res. 2005 Nov-Dec;25(6B):4357-62.PMID: 16309240 [PubMed - indexed for MEDLINE]Related articles

    43.

    Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion.

    Kaliski A, Maggiorella L, Cengel KA, Mathe D, Rouffiac V, Opolon P, Lassau N, Bourhis J, Deutsch E.

    Mol Cancer Ther. 2005 Nov;4(11):1717-28.PMID: 16275993 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors.

    Le Maux Chansac B, Moretta A, Vergnon I, Opolon P, Lécluse Y, Grunenwald D, Kubin M, Soria JC, Chouaib S, Mami-Chouaib F.

    J Immunol. 2005 Nov 1;175(9):5790-8.PMID: 16237071 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway.

    Li H, Soria C, Griscelli F, Opolon P, Soria J, Yeh P, Legrand C, Vannier JP, Belin D, Perricaudet M, Lu H.

    Hum Gene Ther. 2005 Oct;16(10):1157-67.PMID: 16218777 [PubMed - indexed for MEDLINE]Related articles

    46.

    The tumor suppressor activity induced by adenovirus-mediated BRCA1 overexpression is not restricted to breast cancers.

    Marot D, Opolon P, Brailly-Tabard S, Elie N, Randrianarison V, Connault E, Foray N, Feunteun J, Perricaudet M.

    Gene Ther. 2006 Feb;13(3):235-44.PMID: 16208422 [PubMed - indexed for MEDLINE]Related articles

    47.

    In vitro echogenicity characterization of poly[lactide-coglycolide] (plga) microparticles and preliminary in vivo ultrasound enhancement study for ultrasound contrast agent application.

    Lavisse S, Paci A, Rouffiac V, Adotevi C, Opolon P, Peronneau P, Bourget P, Roche A, Perricaudet M, Fattal E, Lassau N.

    Invest Radiol. 2005 Aug;40(8):536-44.PMID: 16024992 [PubMed - indexed for MEDLINE]Related articles

    48.

    Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study.

    Payan C, Roudot-Thoraval F, Marcellin P, Bled N, Duverlie G, Fouchard-Hubert I, Trimoulet P, Couzigou P, Cointe D, Chaput C, Henquell C, Abergel A, Pawlotsky JM, Hezode C, Coudé M, Blanchi A, Alain S, Loustaud-Ratti V, Chevallier P, Trepo C, Gerolami V, Portal I, Halfon P, Bourlière M, Bogard M, Plouvier E, Laffont C, Agius G, Silvain C, Brodard V, Thiefin G, Buffet-Janvresse C, Riachi G, Grattard F, Bourlet T, Stoll-Keller F, Doffoel M, Izopet J, Barange K, Martinot-Peignoux M, Branger M, Rosenberg A, Sogni P, Chaix ML, Pol S, Thibault V, Opolon P, Charrois A, Serfaty L, Fouqueray B, Grange JD, Lefrère JJ, Lunel-Fabiani F.

    J Viral Hepat. 2005 Jul;12(4):405-13.PMID: 15985012 [PubMed - indexed for MEDLINE]Related articles

    49.

    In situ sensory adaptation of tumor-infiltrating T lymphocytes to peptide-MHC levels elicits strong antitumor reactivity.

    Dorothée G, Vergnon I, El Hage F, Le Maux Chansac B, Ferrand V, Lécluse Y, Opolon P, Chouaib S, Bismuth G, Mami-Chouaib F.

    J Immunol. 2005 Jun 1;174(11):6888-97.PMID: 15905531 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with alphavbeta3 and alphavbeta5 integrins.

    Magnon C, Galaup A, Mullan B, Rouffiac V, Bouquet C, Bidart JM, Griscelli F, Opolon P, Perricaudet M.

    Cancer Res. 2005 May 15;65(10):4353-61. Erratum in: Cancer Res. 2005 Jul 1;65(13):5989. Bouquet, Céline [added]. PMID: 15899827 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...